Balance Sheets (Unaudited) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Current assets
Cash and cash equivalents	$ 2,538,758	$ 156,273
Short term investments	7,399,636	0
Accounts receivable, trade, net of allowance for doubtful accounts of $0 at December 31, 2014 and $1,100 at December 31, 2013	901,623	1,009,316
Inventories	965,224	420,924
Prepaid expenses and other current assets	360,521	291,745
Total current assets	12,165,762	1,878,258
Property and equipment
Leasehold improvements	1,284,491	1,121,362
Furniture and computer equipment	476,788	300,581
Manufacturing and other equipment	972,386	764,258
Subtotal	2,733,665	2,186,201
Less: Accumulated depreciation	(1,078,060)	(862,157)
Net property and equipment	1,655,605	1,324,044
Intangible asset	2,215,385	0
Long term deposits	36,166	36,166
Deferred financing costs, net	0	114,874
Total assets	16,072,918	3,353,342
Current liabilities
Accounts payable	474,662	867,070
Accrued expenses and other current liabilities	121,869	146,626
Accrued compensation	535,029	503,194
Deferred rent	130,216	111,250
Total current liabilities	1,261,776	1,628,140
Long term liabilities
Promissory notes payable, related parties	0	10,603,127
Accrued interest, related parties	0	3,501,610
Deferred rent, long term	874,825	891,986
Total liabilities	2,136,601	16,624,863
Commitments and Contingencies (Note 10)
Shareholders' equity (deficiency)
Common stock, $0.001 par value; 150,000,000 shares authorized, 12,084,859 and 5,031,336 shares issued and outstanding at December 31, 2014 and 2013	12,084	5,030
Additional paid-in capital	71,911,328	43,618,686
Accumulated other comprehensive (loss)	(6,448)	0
Accumulated deficit	(60,112,987)	(56,895,237)
Total shareholders' equity (deficiency)	11,803,977	(13,271,521)
Total non-controlling interest equity (deficiency)	2,132,340	0
Total BioLife Solutions, Inc. shareholders' equity (deficiency)	13,936,317	(13,271,521)
Total liabilities and shareholders' equity (deficiency)	$ 16,072,918	$ 3,353,342